Solifenacin

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 990 publications

Reply to Editorial Comment on "Quantitative assessment of additive effects of mirabegron and solifenacin in overactive bladder: re-analysis of SYNERGY study".

Reply to Editorial Comment on "Quantitative assessment of additive effects of mirabegron and solifenacin in overactive bladder: re-analysis of SYNERGY study".

Journal: Urology

Published: July 27, 2026

Editorial Comment on "Quantitative assessment of additive effects ofmirabegrin and solifenacin in overactive bladder: re-analysis of SYNERGY study".

Editorial Comment on "Quantitative assessment of additive effects ofmirabegrin and solifenacin in overactive bladder: re-analysis of SYNERGY study".

Journal: Urology

Published: July 11, 2026

Correction: Efficacy and safety of mirabegron versus solifenacin in the treatment of overactive bladder in children: a systematic review and meta-analysis.

Correction: Efficacy and safety of mirabegron versus solifenacin in the treatment of overactive bladder in children: a systematic review and meta-analysis.

Journal: BMC urology

Published: May 29, 2026

Sex- and Age-Specific Trends in Prescriptions of Beta-3 Agonists and Anticholinergics in Japan: A Nationwide Prescription Database Study.

Sex- and Age-Specific Trends in Prescriptions of Beta-3 Agonists and Anticholinergics in Japan: A Nationwide Prescription Database Study.

Journal: Lower urinary tract symptoms

Published: May 20, 2026

Pharmacological Management of Stress Urinary Incontinence with Atypical Leakage Features, Symptom Response to Short-Term Solifenacin Trial.

Pharmacological Management of Stress Urinary Incontinence with Atypical Leakage Features, Symptom Response to Short-Term Solifenacin Trial.

Journal: International urogynecology journal

Published: May 16, 2026

Long-term efficacy and safety of solifenacin, mirabegron, and their combination for overactive bladder: a systematic review.

Long-term efficacy and safety of solifenacin, mirabegron, and their combination for overactive bladder: a systematic review.

Journal: Frontiers in pharmacology

Published: May 07, 2026

M3 muscarinic receptor antagonism attenuates cocaine-induced hippocampal oligodendroglial changes and relapse-like behavior in male mice.

M3 muscarinic receptor antagonism attenuates cocaine-induced hippocampal oligodendroglial changes and relapse-like behavior in male mice.

Journal: Neuropharmacology

Published: April 27, 2026

Interventions for the Management of Bladder Spasms in Adults with Indwelling Urinary Catheters: A Nursing Practice-Oriented Systematic Review.

Interventions for the Management of Bladder Spasms in Adults with Indwelling Urinary Catheters: A Nursing Practice-Oriented Systematic Review.

Journal: Investigacion y educacion en enfermeria

Published: April 14, 2026

Comment on "Pharmacological Management of Stress Urinary Incontinence with Atypical Leakage Features, Symptom Response to Short-term Solifenacin Trial".

Comment on "Pharmacological Management of Stress Urinary Incontinence with Atypical Leakage Features, Symptom Response to Short-term Solifenacin Trial".

Journal: International urogynecology journal

Published: April 14, 2026

Double versus standard dose of tamsulosin with solifenacin for management of ureteral stent related symptoms.

Double versus standard dose of tamsulosin with solifenacin for management of ureteral stent related symptoms.

Journal: Arab journal of urology

Published: April 06, 2026

Is urinary myelin basic protein the key to understanding the role of vitamin D supplementation in paediatric overactive bladder-dry? Results from a three-stage clinical investigation.

Is urinary myelin basic protein the key to understanding the role of vitamin D supplementation in paediatric overactive bladder-dry? Results from a three-stage clinical investigation.

Journal: BJU international

Published: March 19, 2026

Quantitative Assessment of Additive Effects of Mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study.

Quantitative Assessment of Additive Effects of Mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study.

Journal: Urology

Published: March 17, 2026

Showing 1-12 of 990

Last Updated: 09/26/2026